HOUSTON, TEXAS. Pharm-Olam International Ltd., a multi-national, full-service Clinical Research Solutions Organization to the biopharmaceutical and medical device industries, is pleased to welcome Miguel Salcedo to its management team as Regional Director, Clinical Operations.
MAY 24, 2016
HOUSTON, TEXAS. Pharm-Olam International Ltd., a multi-national, full-service Clinical Research Solutions Organization to the biopharmaceutical and medical device industries, is pleased to welcome Miguel Salcedo to its management team as Regional Director, Clinical Operations.
Mr. Salcedo will be responsible for operations and oversight in Pharm-Olam’s Western Europe and South African offices, and will assist with Pharm-Olam’s ongoing development initiatives in Asia and Latin America. Mr. Salcedo brings to Pharm-Olam over 22 years of Clinical Research Operations, Business Development and Project Management experience.
“We are very excited about having Miguel join Pharm-Olam,” said Sanjiv Suri, Pharm-Olam’s Chief Executive Officer (USA). Mr. Suri added, “Miguel will play a significant role in the execution of projects in Western Europe and South Africa and his past experience will benefit us during our ongoing expansion of our services in Asia and Latin America, where we anticipate significant growth in clinical research activity. By leveraging Miguel’s past experience and knowledge, we will better serve our clients through resource optimization and efficiency improvements.”
For more information about Pharm-Olam and its global Phase I-IV clinical research solutions, contact info@pharm-olam.com (link sends e-mail).
About Pharm-Olam International Group
Pharm-Olam International is a multi-national Contract Research Organization (CRO) offering a wide range of comprehensive, clinical research services to the pharmaceutical, biotechnology and medical device industries. From Phase I to Phase IV, Pharm-Olam focuses on delivering the highest quality data, achieving targeted enrollment and meeting projected timelines. For further information about Pharm-Olam, please visit www.pharm-olam.com.